Suppression of secondary hyperparathyroidism in children with chronic renal failure by high dose phosphate binders: Calcium carbonate versus aluminium hydroxide

British Medical Journal (Clinical research ed.)

Volumn 291, Issue 6496, 1985, Pages 623-627

  Mak, R H ^a   Turner, C ^a   Thompson, Thea ^a   Powell, Helen ^a   Haycock, G B ^a   Chantler, C ^a  

^a EVELINA LONDON CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM HYDROXIDE; CALCITRIOL; CALCIUM CARBONATE; COLECALCIFEROL; CYCLIC AMP; DIHYDROTACHYSTEROL; PHOSPHATE; PHOSPHATE BINDING AGENT;

BONE; BONE BIOPSY; CASE REPORT; CHILD; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSIS; DIET; DRUG COMPARISON; DRUG EFFICACY; DRUG INHIBITION; DRUG TOXICITY; ENDOCRINE SYSTEM; GROWTH RATE; HUMAN; INTOXICATION; KIDNEY; ORAL DRUG ADMINISTRATION; PHOSPHATE BLOOD LEVEL; PLASMA; PRELIMINARY COMMUNICATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SECONDARY HYPERPARATHYROIDISM; THERAPY; URINE;

ADOLESCENT; ALUMINUM HYDROXIDE; CALCIUM CARBONATE; CHILD; CHILD, PRESCHOOL; CLINICAL TRIALS; FEMALE; HUMANS; HYPERPARATHYROIDISM, SECONDARY; KIDNEY FAILURE, CHRONIC; MALE; PARATHYROID HORMONE; PHOSPHATES; RANDOM ALLOCATION;

EID: 0022349693     PISSN: 02670623     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.291.6496.623     Document Type: Article

References (10)

1. Slatopolsky E, Martin K, Hruska K. Parathyroid hormone metabolism and its potential as a uremic toxin. Am J Physiol 1980;239:F1-12.
2. Massry SG, Goldstein DA. The search for uremic toxin(s) “X” “X”=PTH. Clin Nephrol 1979;11:181-9.
3. Stickler GB, Bergen BJ. A review: short stature in renal disease. Pediatr Res 1973;7:978-82.
4. Slatopolsky E, Caglar S, Penell JP, et al. On the pathogenesis of hyperparathyroidism in chronic experimental renal insufficiency in the dog. J Clin Invest 1971;50:492-9.
5. Slatopolsky E, Caglar S, Gradowska J, et al. On the prevention of secondary hyperparathyroidism in experimental chronic renal disease using proportional reduction of dietary phosphorus intake. Kidney Int 1972;2:147-52.
6. Kaplan MA, Canterbury JM, Bourgoigne JJ, et al. Reversal of hyperparathyroidism in response to dietary phosphorus restriction in the uremic dog. Kidney Int 1978;15:43-48.
7. Poisson M, Masmaly R, Lebkiri B. Dialysis encephalopathy: recovery after interruption of aluminium intake. Br Med J 1978;2:1610-161l.
8. Andreoli SP, Bergstein JM, Sherrand DJ. Aluminium intoxication from aluminium containing phosphate binders in children with azotemia not undergoing hemodialysis. N Engl J Med 1984;310:1079-84.
9. Clarkson EM, McDonald SJ, De Wardener HE. The effect of a high intake of calcium carbonate in normal subjects and patients with chronic renal failure. Clin Sci 1966;30:425-38.
10. Moriniere PH, Roussel A, Tahiri Y, et al. Substitution of aluminium hydroxide by high doses of calcium carbonate in patients on chronic haemodialysis disappearance of hyperalurnininaemia and equal control of hyperparathyroidism. Proc Eur Dial Transplant Assoc 1982;19:784-7.